Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.

Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...

Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by ...

Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today issued ...

Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS ...

The September 19, 2024 Annual Meeting is fast approaching, and it’s important to vote as soon as possible. The Company urges stockholders to vote “FOR” Masimo’s director nominees, Joe Kiani and ...

In summer 2022 an enormous fish kill was observed in the Oder River as a consequence of prymnesins produced by an algal bloom. An investigation of the exposure of aquatic life and human cells to ...

Root Signals Inc., a startup that helps companies monitor the reliability of their artificial intelligence models, has closed a $2.8 million investment to advance its growth plans. The funding ...

An entity that hopes to gain access to Masimo’s leading patient monitoring advanced algorithms and sensor technologies IP? The prospect of an anonymous entity using Politan as a tool to take ...

The FINEARTS-HF trial showed that in patients with symptomatic HF with preserved or mildly reduced LVEF, finerenone resulted in a lower composite rate of worsening HF events and CV death compared with ...